Full-Time

Analyst Oracle EBS Software Assurance

ICU Medical

ICU Medical

5,001-10,000 employees

IV therapy systems and safety solutions

No salary listed

Chennai, Tamil Nadu, India

In Person

Category
QA & Testing (2)
,
Required Skills
Agile
SCRUM

Get referred to ICU Medical

See people who can refer or advise you

Requirements
  • BA/BS in Computer Science, Information Systems, or related field
  • Minimum of 5+ years' experience in IT analysis, design and implementation with focus on Oracle EBS QA Testing
  • Experience with Oracle EBS R12 modules: Manufacturing, Order Management, Service, Finance, WMS
  • Working knowledge of data migration, sampling methods, test approaches, and overall process
  • Experience with 3rd party vendor integrations with ERP System
  • Ability to create technical documentation, analyze and translate requirements and user stories into test scripts
  • Strong knowledge of QA processes and methodologies; attention to detail; written and verbal communication skills; interpersonal skills; and time management skills
  • Experienced with various software development processes (Scrum, Agile, XP, Kanban, etc.) from the test design, test automation, and execution perspective
  • Experience with test management tool (ex: HPALM, Validation Master, Visual Studio)
  • Experience with test automation experience (ex: Ranorex, UFT, TestComplete, JMeter, Loadrunner, NeoLoad etc.)
  • Must have good organizational, presentation, meeting facilitation and technical writing skills, high level of resourcefulness to resolve problems when less than adequate information is available
Desired Qualifications
  • Masters degree in Computer Science, Information Systems, or related field
  • Experience working on large projects (upgrades, migrations, mergers)

ICU Medical focuses exclusively on IV therapy across the care continuum. It develops and supplies IV therapy systems, software, and consumables designed to fit existing clinical workflows and improve patient safety and experience. Its product line includes dedicated and non-dedicated IV sets and needle-free connectors that reduce bacterial transfer, a broad range of IV smart pumps for large-volume, pain-management, and ambulatory use, and IV medication safety software that interoperates with IV-EHR systems to support safer, more efficient care. The company differentiates itself by being 100% focused on IV therapy (a result of acquiring Hospira Infusion Systems) with extensive manufacturing and supply capabilities and the broadest IV pump portfolio, enabling strong compatibility with many EHR systems. ICU Medical’s goal is to improve the safety and efficiency of IV therapy and strengthen the clinical experience for patients and caregivers.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Clemente, California

Founded

1984

Get referred to ICU Medical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue beat estimates, and adjusted EPS of $1.97 also beat.
  • Gross margin rose above 41%, showing simplification is improving profitability.
  • Free cash flow reached $28 million, with full-year guidance near $150 million.

What critics are saying

  • FDA approval delays can postpone hardware launches and slow replacement-cycle revenue.
  • Tariff, freight, and logistics costs pressure margins, including a $10 million 2026 headwind.
  • Vital Care exits and IV Solutions deconsolidation suppress reported revenue growth.

What makes ICU Medical unique

  • Infusion Systems and consumables grew organically in Q1 2026, led by large-volume pumps.
  • ICU Medical is exiting non-core products, concentrating on infusion therapy and profitability.
  • Its installed pump base enters a multiyear replacement cycle, supporting refresh demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

AVATAR Group
Apr 2nd, 2026
Paths to precision: choosing the right vascular access device.

Paths to precision: choosing the right vascular access device. Posted on 2 April 2026 Selecting the appropriate vascular access device is crucial for effective patient care and treatment outcomes... *. ICU Medical has provided grant funding to AVATAR

ICU Medical
May 15th, 2025
ICU Medical and VisionHealth Launch MyAcapella(TM) Digital OPEP Coach to Improve OPEP Therapy and Adherence for Respiratory Patients

May 15, 2025 - ICU Medical Inc. (NASDAQ:ICUI), in collaboration with VisionHealth GmbH, has announced the launch of MyAcapella, a mobile application designed to support Oscillating Positive Expiratory Pressure (OPEP) therapy for patients with chronic respiratory conditions.